Overview

Significance of B-lymphocyte antigen CD19 Expression Positive in Diseases

B-Cell Acute Lymphoblastic Leukemia +

Non-Hodgkin Lymphoma +

Acute Lymphoblastic Leukemia +

Diffuse Large B-Cell Lymphoma +

B-Cell Non-Hodgkin Lymphoma +

Chronic Lymphocytic Leukemia +

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma +

Mantle Cell Lymphoma +

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified +

Lymphoma +

Mediastinal Large B-Cell Lymphoma +

Follicular Lymphoma +

Acute Leukemia +

Burkitt Lymphoma +

Double-Hit Lymphoma +

Hairy Cell Leukemia +

Leukemia +

B-Cell Neoplasm +

B-Cell Prolymphocytic Leukemia +

Hematopoietic And Lymphoid Malignancy +

High Grade B-Cell Lymphoma, Not Otherwise Specified +

Hodgkin Lymphoma +

Marginal Zone Lymphoma +

Mediastinal B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma And Classical Hodgkin Lymphoma +

Mediastinal Lymphoma +

Mixed Phenotype Acute Leukemia +

Richter Syndrome +

Small Lymphocytic Leukemia +

Small Lymphocytic Lymphoma +

T-Cell/Histiocyte-Rich Large B-Cell Lymphoma +

Transformed Lymphoma +

Triple-Hit Lymphoma +

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20170629. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. Liu X, Wu C, Li C, and Boerwinkle E. dbNSFP v3.0: A one-stop database of functional predictions and annotations for human nonsynonymous and splice site SNVs. Human Mutation. 2015;37:235-241.

Liu X, Jian X, and Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Human Mutation. 2011;32:894-899.

4. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 4. This dataset does not represent the totality of the genetic landscape; see paper for more information.

5. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.